Here we will overview the recent progress that revealed a new paradigm on the pathogenesis of pulmonary fibrosis and will discuss a new therapeutic strategy by targeting both CHIT1 and CHI3L1. The gene discussed is CHI3L1; the disease is pulmonary fibrosis.